AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9137327 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking status among men.
Number of subjects: 2626
Study 8148464 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical therapeutic strategies aimed at inhibiting selected pathways
Number of subjects: 0
Study 8148464 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental studies focusing on the activities of single cytokines
Number of subjects: 0
Study 8148464 — intervention group
Group type: EXPERIMENTAL
Intervention: More precise delineation of the roles of each mechanism contributing to pathogenesis
Number of subjects: 0
Study 8148464 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of additional approaches to prevention and treatment
Number of subjects: 0
Study 3555597 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% tretinoin cream applied nightly after 5% 5-fluorouracil (5-FU) cream applied twice daily
Number of subjects: 19
Study 3555597 — intervention group
Group type: COMPARATOR
Intervention: Control cream applied nightly after 5% 5-fluorouracil (5-FU) cream applied twice daily
Number of subjects: 19
Study 29458906 — intervention group
Group type: EXPERIMENTAL
Intervention: PEAK Plasma Blade
Number of subjects: 40
Study 29458906 — intervention group
Group type: COMPARATOR
Intervention: Scalpel
Number of subjects: 40
Study 26917566 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor collateral status (hypoperfusion intensity ratio ≤0.4)
Number of subjects: 141
Study 26917566 — intervention group
Group type: COMPARATOR
Intervention: Good collateral status (hypoperfusion intensity ratio >0.4)
Number of subjects: 141
Study 25664215 — intervention group
Group type: EXPERIMENTAL
Intervention: Milnacipran (100-200 mg/d, dosed twice a day)
Number of subjects: 11
Study 25664215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 22376088 — intervention group
Group type: COMPARATOR
Intervention: Passive insulation
Number of subjects: 200
Study 22376088 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air skin surface warming for 10 min
Number of subjects: 200
Study 22376088 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air skin surface warming for 20 min
Number of subjects: 200
Study 22376088 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced-air skin surface warming for 30 min
Number of subjects: 200
Study 20473258 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 0
Study 20473258 — intervention group
Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 0
Study 19127785 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine polyestex gum
Number of subjects: 43
Study 19127785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 16111420 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial cochlear implant insertion (8 electrodes)
Number of subjects: 25
Study 16111420 — intervention group
Group type: COMPARATOR
Intervention: Full cochlear implant insertion
Number of subjects: 25
Study 12051106 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthesized pheromone, topically applied
Number of subjects: 3
Study 12051106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 10424386 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacid-modified resin composite (compomer)
Number of subjects: 50
Study 10424386 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer cement
Number of subjects: 50
Study 10424386 — intervention group
Group type: COMPARATOR
Intervention: Resin composite
Number of subjects: 50
Study 8685642 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (100 mg b.i.d. per os)
Number of subjects: 123
Study 8685642 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole (100 mg b.i.d. per os)
Number of subjects: 123
Study 8685642 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 123
Study 8685642 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole
Number of subjects: 123
Study 2408250 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 2000
Study 2408250 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 2000
Study 2408250 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE-inhibitors
Number of subjects: 2000
Study 2408250 — intervention group
Group type: COMPARATOR
Intervention: ISDN and Hydralazine
Number of subjects: 2000
Study 379955 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 60
Study 379955 — intervention group
Group type: EXPERIMENTAL
Intervention: Emetine
Number of subjects: 60
Study 379955 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of metronidazole and emetine
Number of subjects: 60
Study 379955 — intervention group
Group type: COMPARATOR
Intervention: Surgical management (control group)
Number of subjects: 60
Study 379955 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment (including antiamoebic drugs)
Number of subjects: 60
Study 31240743 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcrestal sinus floor elevation (tSFE)
Number of subjects: 54
Study 31240743 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral sinus floor elevation (lSFE)
Number of subjects: 54
Study 27548998 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional carbon dioxide laser combined with betamethasone and salicylic acid solution
Number of subjects: 2
Study 27548998 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone and salicylic acid solution
Number of subjects: 2
Study 27626365 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical prostatectomy
Number of subjects: 1643
Study 27626365 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical radiotherapy with hormones
Number of subjects: 1643
Study 27626365 — intervention group
Group type: EXPERIMENTAL
Intervention: Active monitoring
Number of subjects: 1643
Study 27626365 — intervention group
Group type: COMPARATOR
Intervention: Control group (other treatments)
Number of subjects: 1643
Study 25383998 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD version of La CLAve psychoeducational program
Number of subjects: 218
Study 25383998 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational program of similar length regarding caregiving (control group)
Number of subjects: 218
Study 25383998 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD presentation administered by a community mental health educator
Number of subjects: 218
Study 22813209 — intervention group
Group type: EXPERIMENTAL
Intervention: SYSTANE UD eye drops (preservative-free hydroxypropyl Guar) applied 5 times per day for 3 months
Number of subjects: 28
Study 22813209 — intervention group
Group type: COMPARATOR
Intervention: VISINE INTENSIV 1% EDO eye drops (preservative-free Tamarindus indica seed polysaccharide) applied 5 times per day for 3 months
Number of subjects: 28
Study 20367987 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemocoagulase Agkistrodon (2 U)
Number of subjects: 432
Study 20367987 — intervention group
Group type: COMPARATOR
Intervention: Hemocoagulase Atrox (control)
Number of subjects: 432
Study 20367987 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 432
Study 17825417 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-site phacotrabeculectomy
Number of subjects: 90
Study 17825417 — intervention group
Group type: COMPARATOR
Intervention: 2-site phacotrabeculectomy
Number of subjects: 90
Study 16255877 — intervention group
Group type: EXPERIMENTAL
Intervention: anti-CD(4), CD(8) monoclonal antibodies combined with cyclosporine A
Number of subjects: 41
Study 16255877 — intervention group
Group type: COMPARATOR
Intervention: anti-lymphocyte globulin and cyclosporine A
Number of subjects: 41
Study 12434939 — intervention group
Group type: EXPERIMENTAL
Intervention: Barrier-specific telephone counseling (BSTC)
Number of subjects: 1601
Study 12434939 — intervention group
Group type: COMPARATOR
Intervention: Continuing medical education (CME)
Number of subjects: 1601
Study 10354213 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycaemia (12 mmol L‐1)
Number of subjects: 12
Study 10354213 — intervention group
Group type: COMPARATOR
Intervention: Euglycaemia (4 mmol L‐1)
Number of subjects: 12
Study 7867053 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% chlorhexidine varnish (VCHX)
Number of subjects: 60
Study 7867053 — intervention group
Group type: EXPERIMENTAL
Intervention: 40% chlorhexidine varnish with fluoride (VCHXF)
Number of subjects: 60
Study 7867053 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine-fluoride gel (GCHXF)
Number of subjects: 60
Study 1552582 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose warfarin
Number of subjects: 100
Study 1552582 — intervention group
Group type: COMPARATOR
Intervention: Intermittent pneumatic leg compression
Number of subjects: 100
Study 3888766 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular ceruletide
Number of subjects: 100
Study 3888766 — intervention group
Group type: COMPARATOR
Intervention: Fatty meal
Number of subjects: 100
Study 3888766 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine cholecystokinetic stimulation
Number of subjects: 100
Study 30830545 — intervention group
Group type: EXPERIMENTAL
Intervention: Pie-cut pattern (PCP) fragmentation
Number of subjects: 100
Study 30830545 — intervention group
Group type: COMPARATOR
Intervention: Three-plane chop (TPC)
Number of subjects: 100
Study 30830545 — intervention group
Group type: COMPARATOR
Intervention: No lens fragmentation (NLF)
Number of subjects: 100
Study 29048247 — intervention group
Group type: EXPERIMENTAL
Intervention: Lustful intentions
Number of subjects: 22
Study 29048247 — intervention group
Group type: EXPERIMENTAL
Intervention: Romantic intentions
Number of subjects: 22
Study 29048247 — intervention group
Group type: EXPERIMENTAL
Intervention: Intentions to not love or not lust
Number of subjects: 22
Study 26409030 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg sublingual buprenorphine
Number of subjects: 36
Study 26409030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 25347723 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist-led medication review
Number of subjects: 209
Study 25347723 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 209
Study 24013610 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole (100 mg/day)
Number of subjects: 50
Study 24013610 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 21182555 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer education intervention (PEI)
Number of subjects: 690
Study 21182555 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 690
Study 19342470 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Coping Skills Training (CST) including sessions promoting physical activity, relaxation, cognitive restructuring, communication skills, and problem solving.
Number of subjects: 600
Study 19342470 — intervention group
Group type: COMPARATOR
Intervention: Standardized Medical Care (SMC) including COPD education and symptom monitoring.
Number of subjects: 600
Study 17917503 — intervention group
Group type: EXPERIMENTAL
Intervention: Darusentan (300 mg)
Number of subjects: 115
Study 17917503 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study 15370723 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 60 mg
Number of subjects: 325
Study 15370723 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoricoxib 90 mg
Number of subjects: 325
Study 15370723 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 325
Study 11264560 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 90
Study 11264560 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and Fentanyl
Number of subjects: 90
Study 11264560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 9685512 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 5 mg/day
Number of subjects: 38
Study 9685512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 9685512 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 38
Study 9685512 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 38
Study 8750995 — intervention group
Group type: EXPERIMENTAL
Intervention: Scleral buckling (group A)
Number of subjects: 19
Study 8750995 — intervention group
Group type: EXPERIMENTAL
Intervention: Encircling elements (group B)
Number of subjects: 19
Study 1789394 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate (low dose)
Number of subjects: 0
Study 1789394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7056273 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolmesoxide (300‐900mg daily)
Number of subjects: 6
Study 7056273 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolmesoxide taken with food
Number of subjects: 6
Study 7056273 — intervention group
Group type: COMPARATOR
Intervention: Tolmesoxide taken fasting
Number of subjects: 6
Study 31652193 — intervention group
Group type: EXPERIMENTAL
Intervention: New suture method
Number of subjects: 80
Study 31652193 — intervention group
Group type: COMPARATOR
Intervention: Conventional suture method
Number of subjects: 80
Study 31170967 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based exercise intervention consisting of 3-min sessions of high intensity interval training combined with music, implemented two times a week at school during study periods.
Number of subjects: 0
Study 31170967 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study 27764682 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk containing 2.5ppm fluoride daily (T1)
Number of subjects: 5
Study 27764682 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk containing 5.0ppm fluoride daily (T3)
Number of subjects: 5
Study 27764682 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk containing 2.5ppm fluoride every other day (T2)
Number of subjects: 5
Study 27764682 — intervention group
Group type: COMPARATOR
Intervention: No treatment (T5)
Number of subjects: 5
Study 27764682 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk containing 5.0ppm fluoride every other day (T4)
Number of subjects: 5
Study 25613235 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure Therapy
Number of subjects: 14
Study 23690568 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilingual vocabulary intervention
Number of subjects: 202
Study 23690568 — intervention group
Group type: EXPERIMENTAL
Intervention: English-only vocabulary intervention
Number of subjects: 202
Study 23690568 — intervention group
Group type: COMPARATOR
Intervention: Mathematics intervention
Number of subjects: 202
Study 23690568 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 202
Study 22531514 — intervention group
Group type: EXPERIMENTAL
Intervention: Conformal radiation and temozolamide
Number of subjects: 46
Study 20180429 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu Qiangjing Decoction (SQD)
Number of subjects: 60
Study 20180429 — intervention group
Group type: COMPARATOR
Intervention: Vitamin C tablets plus intramuscular chymotrypsin (Control)
Number of subjects: 60
Study 17587789 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle plus exercise intervention (LIFE+EX)
Number of subjects: 44
Study 17587789 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 44
Study 15072861 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐week physical activity and diet intervention
Number of subjects: 92
Study 15072861 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study 15072861 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 92
Study 11471263 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanic thermometry
Number of subjects: 378
Study 11471263 — intervention group
Group type: COMPARATOR
Intervention: Rectal thermometry
Number of subjects: 378
Study 9495616 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing teeth after 48 hours of no cleaning
Number of subjects: 10
Study 9495616 — intervention group
Group type: COMPARATOR
Intervention: No brushing teeth after 48 hours of no cleaning
Number of subjects: 10
Study 8054332 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education course consisting of a video and booklet with motivational material
Number of subjects: 264
Study 8054332 — intervention group
Group type: COMPARATOR
Intervention: Control group received a video and booklet with no motivational or simplified materials
Number of subjects: 264
Study 8054332 — intervention group
Group type: COMPARATOR
Intervention: Baseline group received no tuition and represented a control of publicly available information
Number of subjects: 264
Study 1659497 — intervention group
Group type: EXPERIMENTAL
Intervention: Kang Er Xin-I (KEX-I) for two weeks
Number of subjects: 26
Study 1659497 — intervention group
Group type: COMPARATOR
Intervention: Coenzyme Q10 (control)
Number of subjects: 26
Study 6118964 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin 0.5 mg
Number of subjects: 9
Study 6118964 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 1 mg
Number of subjects: 9
Study 6118964 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30246888 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed heart model workshop
Number of subjects: 20
Study 30246888 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture
Number of subjects: 20
Study 27825975 — intervention group
Group type: EXPERIMENTAL
Intervention: Office insertion of Reveal LINQ ICM
Number of subjects: 521
Study 27825975 — intervention group
Group type: COMPARATOR
Intervention: Hospital insertion of Reveal LINQ ICM
Number of subjects: 521
Study 25773268 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 90 mg twice daily
Number of subjects: 21162
Study 25773268 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 60 mg twice daily
Number of subjects: 21162
Study 25773268 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21162
Study 24107738 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (25 mg, increased to 50 mg if needed after 4 weeks)
Number of subjects: 119
Study 24107738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 21429079 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice packs on the perineum
Number of subjects: 114
Study 21429079 — intervention group
Group type: COMPARATOR
Intervention: Water packs at set temperature (placebo)
Number of subjects: 114
Study 21429079 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 114
Study 18710427 — intervention group
Group type: EXPERIMENTAL
Intervention: peginterferon α-2a (40KD) plus ribavirin for 16 or 24 weeks
Number of subjects: 885
Study 18710427 — intervention group
Group type: COMPARATOR
Intervention: Steatosis
Number of subjects: 885
Study 17722868 — intervention group
Group type: EXPERIMENTAL
Intervention: Olyset nets
Number of subjects: 3
Study 17722868 — intervention group
Group type: COMPARATOR
Intervention: Untreated nets
Number of subjects: 3
Study 17722868 — intervention group
Group type: COMPARATOR
Intervention: No nets (control)
Number of subjects: 3
Study 15103544 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous epoetin beta (NeoRecormon) to maintain target Hb levels of 13‐15 g/dl
Number of subjects: 160
Study 15103544 — intervention group
Group type: COMPARATOR
Intervention: Current practice (no epoetin therapy until Hb levels decline below 10.5 g/dl)
Number of subjects: 160
Study 15103544 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous epoetin beta (NeoRecormon)
Number of subjects: 160
Study 11328423 — intervention group
Group type: EXPERIMENTAL
Intervention: Varicocelectomy
Number of subjects: 42
Study 11328423 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate, 50 mg/day, orally
Number of subjects: 42
Study 11328423 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate
Number of subjects: 42
Study 9485848 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing care
Number of subjects: 0
Study 7992099 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea
Number of subjects: 0
Study 7992099 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose cytosine arabinoside and IFN-alpha
Number of subjects: 0
Study 7992099 — intervention group
Group type: EXPERIMENTAL
Intervention: Homoharringtonine followed by IFN-alpha
Number of subjects: 0
Study 7992099 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha post-transplant
Number of subjects: 0
Study 7992099 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous bone marrow transplantation
Number of subjects: 0
Study 7992099 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation
Number of subjects: 0
Study 2463564 — intervention group
Group type: EXPERIMENTAL
Intervention: DDDMR (double chamber rate responsive cardiac pacemaker)
Number of subjects: 7
Study 2463564 — intervention group
Group type: COMPARATOR
Intervention: VVIMR (single chamber rate responsive cardiac pacemaker)
Number of subjects: 7
Study 29429908 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD)
Number of subjects: 108
Study 29429908 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) with clobazam
Number of subjects: 108
Study 29429908 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidiol (CBD) without clobazam
Number of subjects: 108
Study 29429908 — intervention group
Group type: COMPARATOR
Intervention: Clobazam alone
Number of subjects: 108
Study 28295915 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid
Number of subjects: 147
Study 28295915 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 147
Study 25300315 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-layer compression bandaging + larvae
Number of subjects: 40
Study 25300315 — intervention group
Group type: COMPARATOR
Intervention: 4-layer compression bandaging
Number of subjects: 40
Study 23052417 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (300 mg)
Number of subjects: 12
Study 23052417 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg)
Number of subjects: 12
Study 23052417 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12